SCHEMBL472245

SCHEMBL472245

NC(=O)c1cccc(C(=O)N2CCCCCCCCCCCC2)c1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.66
LMNA P02545 2/20 0.60
POLB P06746 1/20 0.60
ALDH1A1 P00352 5/20 0.59
GAA P10253 3/20 0.58
L3MBTL3 Q96JM7 2/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
SMN1; SMN2 Q16637 1/20 0.57
KDM4E B2RXH2 1/20 0.56
USP2 O75604 2/20 0.56
MEN1 O00255 1/20 0.55
HTT P42858 1/20 0.55
KMT2A Q03164 1/20 0.55
MAPK1 P28482 2/20 0.55
TP53 P04637 1/20 0.53
MAPT P10636 1/20 0.53
TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL538600 1.00 HPGD (0.66) HPGDLMNAPOLBALDH1A1GAA
SCHEMBL28377650 1.00 HPGD (0.66) HPGDLMNAPOLBALDH1A1GAA
SCHEMBL180076 1.00 HPGD (0.66) HPGDLMNAPOLBALDH1A1GAA
SCHEMBL6902996 1.00 HPGD (0.66) HPGDLMNAPOLBALDH1A1GAA
SCHEMBL369227 1.00 HPGD (0.66) HPGDLMNAPOLBALDH1A1GAA
SCHEMBL367274 1.00 HPGD (0.66) HPGDLMNAPOLBALDH1A1GAA
SCHEMBL538527 1.00 HPGD (0.66) HPGDLMNAPOLBALDH1A1GAA
SCHEMBL472260 1.00 HPGD (0.66) HPGDLMNAPOLBALDH1A1GAA
SCHEMBL367502 0.98 HPGD (0.65) HPGDLMNAPOLBALDH1A1GAA
Terephthalamide SCHEMBL198417 0.97 HPGD (0.62) HPGDLMNAPOLBALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-52008122-A None JP disclosed
US-11254082-B2 Multi-layer tube UBE INDUSTRIES, LTD. (JP) 2022-02-22 US disclosed
CN-108350270-B Polyamide resin composition and film 宇部兴产株式会社 2021-05-11 CN disclosed
CN-107635771-B Laminated body AGC株式会社 2020-12-18 CN disclosed
US-10663092-B2 Multilayer tube UBE INDUSTRIES, LTD. (JP) 2020-05-26 US disclosed
EP-3042758-B1 LAMINATED TUBE UBE INDUSTRIES (JP) 2020-05-06 EP disclosed
EP-3461631-A1 MULTILAYER TUBE Ube Industries, Ltd. (JP) 2019-04-03 EP disclosed
EP-3192650-B1 LAYERED TUBE UBE INDUSTRIES (JP) 2019-01-23 EP disclosed
US-20170261133-A1 MULTILAYER TUBE UBE INDUSTRIES, LTD. (JP) 2017-09-14 US disclosed
US-20170204130-A1 FLAME RETARDANTS, PREPARATION METHODS, AND THERMOPLASTIC COMPOSITIONS THEREOF DU PONT (US) 2017-07-20 US disclosed
US-5585429-A CONTAINING LITHIUM HALIDE; REDUCED MELT VISCOSITY AMOCO CORPORATION (US) 1996-12-17 US disclosed
EP-0735082-A2 Polyphtalamide resin formulations AMOCO CORPORATION (US) 1996-10-02 EP disclosed
US-5436294-A Impact modifiers for improved ductility and rigidity AMOCO CORPORATION (US) 1995-07-25 US disclosed
US-5387645-A Synergistic blend of polyamide, functionalized polyolefin and functionalized styrene blocks and rubber blocks of ethylene, propylene, butylene and pentylene; maleic anhydride-modified AMOCO CORPORATION (US) 1995-02-07 US disclosed
US-5292805-A Polypropylene, and carboxyl-modified polypropylene AMOCO CORPORATION (US) 1994-03-08 US disclosed
US-5283284-A Containing carboxylated polypropylene compatibilizer AMOCO CORPORATION (US) 1994-02-01 US disclosed
EP-0572266-A2 Filled polyphthalamide blends having improved processability and composite and filled articles therefrom AMOCO CORPORATION (US) 1993-12-01 EP disclosed
EP-0572267-A1 Polypropylene-polyphthalamide blends AMOCO CORPORATION (US) 1993-12-01 EP disclosed
EP-0477027-A2 Improved polyphthalamide composition AMOCO CORPORATION (US) 1992-03-25 EP disclosed
JP-S528122-A PROCESS FOR DRAWING AND HEAT-TREATING OF ALIPHATIC-AROMATIC POLYAMIDE FILAMENT YARNS TORAY IND INC 1977-01-21 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170204130-A1 FLAME RETARDANTS, PREPARATION METHODS, AND THERMOPLASTIC COMPOSITIONS THEREOF FBP1, RFT1, FRG1 HPGD 2700/4885LMNA 2762/4885POLB 1491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.